TCF3

transcription factor 3
OMIM: 147141, Gene2Phenotype

3 panels

Panel Reviews Mode of inheritance Details
3 panels
Green TCF3 in COVID-19 research


Level 2: Viral research
Version 1.146

review BOTH monoallelic and biallelic, autosomal or pseudoautosomal
Sources
  • IUIS Classification December 2031
  • IUIS Classification February 2018
  • A- or hypo-gammaglobulinaemia v1.25
  • London North GLH
  • NHS GMS
  • Victorian Clinical Genetics Services
  • North West GLH
  • ESID Registry 20171117
  • Expert Review Green
  • NHS GMS
  • North West GLH
  • London North GLH
  • Expert Review Green
  • IUIS Classification February 2018
  • Victorian Clinical Genetics Services
  • ESID Registry 20171117
  • A- or hypo-gammaglobulinaemia v1.25
Phenotypes
  • Agammaglobulinemia 8A, autosomal dominant, OMIM:616941
  • Agammaglobulinemia 8B, autosomal recessive, OMIM:619824
  • Recurrent bacterial infections
  • Predominantly Antibody Deficiencies
Green TCF3 in Primary immunodeficiency or monogenic inflammatory bowel disease


Level 2: Immunology
Version 8.78
Latest signed off version: v8.0 (30 Apr 2025)

review BOTH monoallelic and biallelic, autosomal or pseudoautosomal
Sources
  • NHS GMS
  • North West GLH
  • London North GLH
  • Expert Review Green
  • IUIS Classification February 2018
  • Victorian Clinical Genetics Services
  • ESID Registry 20171117
  • A- or hypo-gammaglobulinaemia v1.25
Phenotypes
  • Agammaglobulinemia 8A, autosomal dominant, OMIM:616941
  • Agammaglobulinemia 8B, autosomal recessive, OMIM:619824
  • Recurrent bacterial infections
  • Predominantly Antibody Deficiencies
Amber TCF3 in Haematological malignancies cancer susceptibility


Level 2: Cancer susceptibility
Version 4.37
Latest signed off version: v4.0 (22 Mar 2023)

review MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Amber
  • Literature
Phenotypes
  • B-cell acute lymphoblastic leukemia, MONDO:0004947
Tags
  • Q2_25_ promote_green
  • Q2_25_expert_review